Skip to main navigation Skip to search Skip to main content

Antiepileptic drug prescribing before, during and after pregnancy: astudy in seven European regions

  • R Charlton
  • , E Garne
  • , H Wang
  • , K Klungsoyr
  • , S Jordan
  • , A Neville
  • , A Pierini
  • , A Hansen
  • , A Engeland
  • , R Gini
  • , D Thayer
  • , J Bos
  • , A Puccini
  • , A-M Nybo Andersen
  • , H Dolk
  • , L de Jong van-den Berg

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose The aim of this study was to explore antiepileptic drug (AED) prescribing before, during and after pregnancy as recorded in sevenpopulation-based electronic healthcare databases.Methods Databases in Denmark, Norway, the Netherlands, Italy (Emilia Romagna/Tuscany), Wales and the Clinical Practice ResearchDatalink, representing the rest of the UK, were accessed for the study. Women with a pregnancy starting and ending between 2004 and2010, which ended in a delivery, were identified. AED prescriptions issued (UK) or dispensed (non-UK) at any time during pregnancyand the 6 months before and after pregnancy were identified in each of the databases. AED prescribing patterns were analysed, and the choiceof AEDs and co-prescribing of folic acid were evaluated.Results In total, 978 957 women with 1 248 713 deliveries were identified. In all regions, AED prescribing declined during pregnancy andwas lowest during the third trimester, before returning to pre-pregnancy levels by 6 months following delivery. For all deliveries, the prev-alence of AED prescribing during pregnancy was 51 per 10 000 pregnancies (CI9549–52%) and was lowest in the Netherlands (43/10 000;CI9533–54%) and highest in Wales (60/10 000; CI9554–66%). In Denmark, Norway and the two UK databases lamotrigine was the mostcommonly prescribed AED; whereas in the Italian and Dutch databases, carbamazepine, valproate and phenobarbital were most frequentlyprescribed. Few women prescribed with AEDs in the 3 months before pregnancy were co-prescribed with high-dose folic acid: ranging from1.0% (CI950.3–1.8%) in Emilia Romagna to 33.5% (CI9528.7–38.4%) in Wales.Conclusion The country’s differences in prescribing patterns may suggest different use, knowledge or interpretation of the scientific evi-dence base. The low co-prescribing of folic acid indicates that more needs to be done to better inform clinicians and women of childbearingage taking AEDs about the need to offer and receive complete preconception care.
Original languageEnglish
Pages (from-to)1144-1154
JournalPharmacoepidemiology and Drug Safety
Volume24
Early online date13 Aug 2015
DOIs
Publication statusPublished online - 13 Aug 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • anticonvulsants
  • pregnancy
  • drug utilisation
  • electronic health records
  • pharmacoepidemiology

Fingerprint

Dive into the research topics of 'Antiepileptic drug prescribing before, during and after pregnancy: astudy in seven European regions'. Together they form a unique fingerprint.

Cite this